Tower Research Capital LLC (Trc) Amylyx Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 9,640 shares of AMLX stock, worth $35,186. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,640
Previous 31,936
69.81%
Holding current value
$35,186
Previous $60,000
48.33%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMLX
# of Institutions
124Shares Held
43.9MCall Options Held
235KPut Options Held
530K-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$16.9 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$11.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$9.74 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$7.76 Million0.18% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.02MShares$7.39 Million0.04% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $214M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...